معرفی
Professor Iain McNeish is a leading researcher in ovarian cancer at the University of Glasgow's School of Cancer Sciences, with extensive expertise in molecular oncology, cancer therapeutics, and genomic analysis of high-grade serous carcinoma. His work bridges basic science and clinical applications, focusing on improving outcomes for ovarian cancer patients through innovative therapeutic approaches.
Dr. McNeish's research interests center on ovarian cancer biology and treatment, with particular emphasis on:
- Molecular mechanisms of ovarian cancer development and progression
- Oncolytic viral therapies for ovarian cancer
- Genomic analysis of high-grade serous ovarian carcinoma
- BRCA mutations and PARP inhibitor resistance mechanisms
- Platinum resistance in ovarian cancer
- Development of novel targeted therapies for ovarian cancer
His extensive publication record demonstrates a consistent focus on translating genomic discoveries into clinical applications. McNeish's work has significantly contributed to understanding the molecular subtypes of ovarian cancer, mechanisms of therapy resistance, and development of novel therapeutic approaches including viral therapies. His research often involves large collaborative efforts with international consortia, reflecting the complex, multidisciplinary nature of modern cancer research.
Dr. McNeish has been involved in numerous clinical trials investigating new treatments for ovarian cancer, particularly focusing on overcoming resistance to standard therapies. His work on oncolytic adenoviruses has demonstrated promising results in enhancing cancer cell killing while minimizing toxicity.
